POU4F1 Drives Colorectal Cancer Progression by Promoting Cell Proliferation, Metastasis, and Chemoresistance
Digestion · 2025
DOI: 10.1159/000548266 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestion, 2025. Verfasst von HaiLi Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Drug Resistance, Neoplasm, Neoplasm Recurrence, Local. Die Arbeit nennt 38 Literaturangaben.
Abstract (Originalsprache)
Introduction
Colorectal cancer remains one of the most prevalent gastrointestinal malignancies. This study aims to identify key genes associated with colorectal cancer recurrence, offering novel insights for prognostic assessment and personalized treatment strategies.
Methods
Leveraging the TCGA dataset, we conducted a comprehensive analysis of differentially expressed genes between recurrent and nonrecurrent colorectal cancer patients. We developed a recurrence-associated gene signature (RAGS) model for prognostic evaluation and employed nine machine learning algorithms to predict recurrence risk. Furthermore, we performed extensive functional studies on the most significant genes, examining their expression patterns, prognostic relevance, and effects on cellular proliferation, metastasis, and chemoresistance.
Results
Our analyses identified 45 key genes linked to colorectal cancer recurrence and prognosis. Using LASSO regression, we constructed the RAGS model, incorporating TMEM213, SAP25, POU4F1, RSPO4, and PAGE2B. This model demonstrated exceptional performance in predicting overall prognosis and post-chemotherapy outcomes. Among the machine learning algorithms tested, XGBoost exhibited the highest diagnostic accuracy for recurrence prediction, with POU4F1 emerging as the most significant predictive gene. Functional experiments revealed that POU4F1 knockdown substantially inhibited colorectal cancer cell proliferation and metastasis both in vitro and in vivo, while also reducing resistance to 5-fluorouracil and oxaliplatin.
Conclusion
This study successfully identified crucial genes associated with colorectal cancer recurrence and developed a robust RAGS prognostic model. The XGBoost algorithm underscored the importance of POU4F1 in predicting colorectal cancer recurrence. Our functional analysis of POU4F1 provides fresh insights into colorectal cancer progression mechanisms and informs the development of targeted therapeutic approaches. These findings not only enhance our understanding of colorectal cancer’s molecular underpinnings but also establish a solid foundation for advancing precision diagnosis and treatment in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
- Department of Anesthesiology, Sinopharm North Hospital, Baotou, China.
- Fujian-Macao Science and Technology Cooperation Base of Traditional Chinese Medicine-Oriented Chronic Disease Prevention and Treatment, Innovation and Transformation Center, Fujian University of Traditional Chinese Medi…
- Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China, 13799322969@163.com.
- Department of Gastrointestinal Surgery, Fujian Provincial Hospital, Fuzhou, China, 13799322969@163.com.
- Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China, xuefangqingsl@sina.com.
Zitieren
APA
Li, H., Gao, P., Wang, Q., Xu, C., & Xue, F. (2025). POU4F1 Drives Colorectal Cancer Progression by Promoting Cell Proliferation, Metastasis, and Chemoresistance. Digestion. https://doi.org/10.1159/000548266
Vancouver
Li H, Gao P, Wang Q, Xu C, Xue F. POU4F1 Drives Colorectal Cancer Progression by Promoting Cell Proliferation, Metastasis, and Chemoresistance. Digestion. 2025. doi:10.1159/000548266
BibTeX
@article{Li2025,
author = {Li, HaiLi and Gao, PeiZhen and Wang, QingShui and Xu, Chao and Xue, FangQin},
title = {POU4F1 Drives Colorectal Cancer Progression by Promoting Cell Proliferation, Metastasis, and Chemoresistance},
journal = {Digestion},
year = {2025},
doi = {10.1159/000548266}
}
EUVIMED